BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 31970828)

  • 1. Costs and outcomes of "intermediate" vs "minimal" care for youth-onset type 1 diabetes in six countries.
    Gregory GA; Guo J; Klatman EL; Ahmadov GA; Besançon S; Gomez ED; Fawwad A; Ramaiya K; Wijesuriya MA; Orchard TJ; Ogle GD
    Pediatr Diabetes; 2020 Jun; 21(4):628-636. PubMed ID: 31970828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of type 1 diabetes care in children and adolescents for countries at varying resource levels.
    Ogle GD; von Oettingen JE; Middlehurst AC; Hanas R; Orchard TJ
    Pediatr Diabetes; 2019 Feb; 20(1):93-98. PubMed ID: 30471084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Mortality Rates and Clinical Characteristics of Type 1 Diabetes among Children and Young Adults in Cochabamba, Bolivia.
    Duarte Gómez E; Gregory GA; Castrati Nostas M; Middlehurst AC; Jenkins AJ; Ogle GD
    J Diabetes Res; 2017; 2017():8454757. PubMed ID: 28948172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial costs for families of children with Type 1 diabetes in lower-income countries.
    Ogle GD; Kim H; Middlehurst AC; Silink M; Jenkins AJ
    Diabet Med; 2016 Jun; 33(6):820-6. PubMed ID: 26482333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
    Siegel KR; Ali MK; Zhou X; Ng BP; Jawanda S; Proia K; Zhang X; Gregg EW; Albright AL; Zhang P
    Diabetes Care; 2020 Jul; 43(7):1557-1592. PubMed ID: 33534729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological care in children and adolescents with type 1 diabetes in a real-world setting and associations with metabolic control.
    Galler A; Hilgard D; Bollow E; Hermann T; Kretschmer N; Maier B; Mönkemöller K; Schiel R; Holl RW
    Pediatr Diabetes; 2020 Sep; 21(6):1050-1058. PubMed ID: 32506592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
    Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
    Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis.
    Tunis SL; Minshall ME; Conner C; McCormick JI; Kapor J; Yale JF; Groleau D
    Curr Med Res Opin; 2009 May; 25(5):1273-84. PubMed ID: 19366302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing costs of type 1 diabetes care among US children and adolescents.
    Crossen S; Xing G; Hoch JS
    Pediatr Diabetes; 2020 Jun; 21(4):644-648. PubMed ID: 32061049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of thiazolidinediones in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand.
    Chirakup S; Chaiyakunapruk N; Chaikledkeaw U; Pongcharoensuk P; Ongphiphadhanakul B; Roze S; Valentine WJ; Palmer AJ
    Value Health; 2008 Mar; 11 Suppl 1():S43-51. PubMed ID: 18387067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
    Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
    Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and characteristics of childhood- and youth-onset diabetes in the Qalandarabad area in northern Pakistan.
    Condie AM; Allen TV; Ogle GD
    Diabetes Res Clin Pract; 2020 May; 163():108155. PubMed ID: 32333971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid increases in observed incidence and prevalence of Type 1 diabetes in children and youth in Mali, 2007-2016.
    Sandy JL; Besançon S; Sidibé AT; Minkailou M; Togo A; Ogle GD
    Pediatr Diabetes; 2021 Jun; 22(4):545-551. PubMed ID: 33586301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
    Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
    Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The socioeconomic correlates of global complication prevalence in type 1 diabetes (T1D): a multinational comparison.
    Walsh MG; Zgibor J; Songer T; Borch-Johnsen K; Orchard TJ;
    Diabetes Res Clin Pract; 2005 Nov; 70(2):143-50. PubMed ID: 16188576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes.
    Mahmud FH; Elbarbary NS; Fröhlich-Reiterer E; Holl RW; Kordonouri O; Knip M; Simmons K; Craig ME
    Pediatr Diabetes; 2018 Oct; 19 Suppl 27(Suppl 27):275-286. PubMed ID: 30066458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.